(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
2.47% $ 11.21
@ $12.36
Выпущен: 14 февр. 2024 @ 17:30
Доходность: -9.30%
Предыдущий сигнал: февр. 12 - 23:00
Предыдущий сигнал:
Доходность: -1.98 %
Live Chart Being Loaded With Signals
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation...
Stats | |
---|---|
Объем за сегодня | 112 701 |
Средний объем | 205 652 |
Рыночная капитализация | 360.63M |
EPS | $0 ( 2024-04-25 ) |
Дата следующего отчета о доходах | ( $0.0300 ) 2024-05-16 |
Last Dividend | $0.100 ( 2022-01-05 ) |
Next Dividend | $0 ( N/A ) |
P/E | 41.52 |
ATR14 | $0.0110 (0.10%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-25 | Moorhead Daniel J | Sell | 6 084 | Common Stock |
2024-03-25 | Lucsok Anna | Sell | 7 672 | Common Stock |
2024-03-25 | Sandgaard Thomas | Sell | 2 268 | Common Stock |
2024-03-05 | Moorhead Daniel J | Buy | 5 000 | Common Stock (Restricted Stock Award) |
2024-01-27 | Lucsok Anna | Buy | 5 000 | Common Stock (Restricted Stock Award) |
INSIDER POWER |
---|
-38.25 |
Last 100 transactions |
Buy: 368 705 | Sell: 936 982 |
Объем Корреляция
Zynex Inc Корреляция
10 Самые положительные корреляции | |
---|---|
MMAC | 0.896 |
BOCH | 0.863 |
BMRN | 0.848 |
CTRN | 0.841 |
STRO | 0.838 |
XEL | 0.832 |
CAAS | 0.826 |
ISRG | 0.821 |
AMRB | 0.814 |
GLSI | 0.812 |
10 Самые отрицательные корреляции | |
---|---|
APOP | -0.971 |
RMRM | -0.939 |
MAGS | -0.936 |
TDAC | -0.897 |
CMLF | -0.868 |
SVOK | -0.836 |
EMBCV | -0.824 |
TLGT | -0.823 |
SPRT | -0.82 |
TALS | -0.82 |
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Zynex Inc Корреляция - Валюта/Сырье
Zynex Inc Финансовые показатели
Annual | 2023 |
Выручка: | $184.32M |
Валовая прибыль: | $145.96M (79.19 %) |
EPS: | $0.270 |
FY | 2023 |
Выручка: | $184.32M |
Валовая прибыль: | $145.96M (79.19 %) |
EPS: | $0.270 |
FY | 2022 |
Выручка: | $158.17M |
Валовая прибыль: | $126.16M (79.77 %) |
EPS: | $0.440 |
FY | 2021 |
Выручка: | $130.30M |
Валовая прибыль: | $102.98M (79.03 %) |
EPS: | $0.450 |
Financial Reports:
No articles found.
Zynex Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.136 | 2014-06-17 |
Last Dividend | $0.100 | 2022-01-05 |
Next Dividend | $0 | N/A |
Payout Date | 2022-01-21 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $0.300 | -- |
Avg. Dividend % Per Year | 0.21% | -- |
Score | 2.67 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.49 | |
Div. Directional Score | 7.84 | -- |
Year | Amount | Yield |
---|---|---|
2014 | $0.136 | 42.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0.0636 | 2.14% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0.100 | 1.07% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0528 | 1.500 | 8.94 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0690 | 1.200 | 7.70 | 9.24 | [0 - 0.3] |
returnOnEquityTTM | 0.168 | 1.500 | 9.24 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.000308 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 4.74 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 3.85 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.41 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.436 | -1.500 | 2.73 | -4.10 | [0 - 0.6] |
interestCoverageTTM | 11.13 | 1.000 | 6.99 | 6.99 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.531 | 2.00 | 9.82 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.495 | 2.00 | 9.75 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.334 | -1.500 | 4.66 | -7.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.792 | 1.000 | 0.136 | 0.136 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0661 | 1.000 | -0.678 | -0.678 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.290 | 1.000 | 9.50 | 9.50 | [0.2 - 2] |
assetTurnoverTTM | 1.307 | 0.800 | 4.62 | 3.70 | [0.5 - 2] |
Total Score | 11.20 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 38.70 | 1.000 | 6.19 | 0 | [1 - 100] |
returnOnEquityTTM | 0.168 | 2.50 | 9.51 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.495 | 2.00 | 9.84 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.531 | 2.00 | 9.82 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.000308 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 0.378 | 1.500 | -0.813 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0967 | 1.000 | -0.0814 | 0 | [0.1 - 0.5] |
Total Score | 4.49 |
Zynex Inc
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа